ISSN 2285-1364, ISSN CD-ROM 2285-5521, ISSN ONLINE 2285-1372, ISSN-L 2285-1364


Published in Scientific Bulletin. Series F. Biotechnologies, Vol. XXII
Written by Daniel NIŢOI, Florentina MATEI, Călina Petruţa CORNEA

In recent years, microbial infections have become increasingly difficult to treat. Classical treatments, which involve the use of antibiotics in various pharmaceutical compounds with antimicrobial activity, shows the problems difficult to be solved. For this purpose, researchers are looking for a solution and therefore possible alternative treatments to treat microbial infections. Favorable results are obtained from the use of probiotics, a lot of in vitro and in vivo studies demonstrating the ability of certain probiotics, in particular lactic acid bacteria, to inhibit the growth of pathogenic microorganisms. Probiotics are a class of bacteria similar to those existing in specific human microflora, with beneficial role on human health. Real problems came from endemic fungal infections of humans who, in their favorable conditions, proliferate and lead to the appearance of serious diseases. An example and also a cause of many diseases is the genus Candida. The review presents the main findings related to the response of different Candida species to in vitro and in vivo treatments with different probiotics.

[Read full article] [Citation]

The publisher is not responsible for the opinions published in the Volume. They represent the authors’ point of view.

© 2019 Scientific Bulletin Series F.“Biotechnologies“. All Rights Reserved. To be cited: Scientific Bulletin Series F.“Biotechnologies“.

Powered by INTELIDEV